首页 | 本学科首页   官方微博 | 高级检索  
检索        

三七总皂苷主要成分对人肝微粒体CYP3A4酶的抑制作用研究
引用本文:王凌,程能能,毛玉昌.三七总皂苷主要成分对人肝微粒体CYP3A4酶的抑制作用研究[J].中国药师,2014(3):353-356.
作者姓名:王凌  程能能  毛玉昌
作者单位:上海中医药大学附属岳阳中西医结合医院 上海200437;;复旦大学药学院;;瑞德肝脏疾病研究(上海)有限公司
基金项目:上海市教育委员会预算内科研项目(编号:2011JW44)
摘    要:目的:研究三七总皂苷主要成分人参皂苷Rg1、人参皂苷Rb1和三七皂苷R1对人肝微粒体CYP3A4酶的体外抑制作用.方法:采用人肝微粒体体外孵育法,在孵育体系中分别加入不同浓度的人参皂苷Rg1、人参皂苷Rb1和三七皂苷R1与探针底物睾酮共孵育,用LC-MS /MS 法测定代谢产物6β-羟基睾酮的生成量反映CYP3A4酶活性的影响.结果:人参皂苷Rg1在2~1 000 μmol·L-1的测试浓度范围内对CYP3A4未见剂量相关的抑制作用;人参皂苷Rb1在2~200 μmol·L-1的测试浓度范围内对CYP3A4未见剂量相关的抑制作用,在1 000 μmol·L-1的测试浓度下对CYP3A4具有轻微抑制作用;三七皂苷R1在2~1 000 μmol·L-1的测试浓度范围内对CYP3A4的IC50为126 μmol·L-1(>100 μmol·L-1).结论:三七总皂苷3个主要有效成分单体对CYP3A4酶的体外抑制作用不同,人参皂苷Rg1无抑制作用,人参皂苷Rb1高浓度下有轻微抑制作用,三七皂苷R1有弱抑制作用,三七总皂苷制剂与CYP3A4酶代谢相关的药物之间产生相互作用的可能性低.

关 键 词:人参皂苷Rg1  人参皂苷Rb1  三七皂苷R1  CYP3A4  抑制作用
收稿时间:2013/10/29 0:00:00
修稿时间:2013/12/22 0:00:00

Inhibition of Panax Notoginsenosides on Human Liver Microsomes CYP3A4
Wang Ling,Cheng Nengneng and Mao Yuchang.Inhibition of Panax Notoginsenosides on Human Liver Microsomes CYP3A4[J].China Pharmacist,2014(3):353-356.
Authors:Wang Ling  Cheng Nengneng and Mao Yuchang
Institution:Yueyang Hospital of Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China;;School of Pharmacy, Fudan University;;Research Institute for Liver Diseases (Shanghai) Co. Ltd.
Abstract:Objective : To investigate the inhibitory effect of such main components of Panax notoginsenosides as ginsenoside Rg1, ginsenoside Rbl and notoginsenoside R1 on human liver microsomes CYP3A4 in vitro. Methods: The human liver microsomes were re- spectively incubated with ginsenoside Rgl, ginsenoside Rb1 and notoginsenoside R1 at different concentrations at the present of testoster- one. LC-MS/MS was used to detect the metabolite 613-hydroxytestosterone in the incubation systems to reflect the specific substrate of CYP3A4. Ketoconazole was used as the positive control. Results: Ginsenoside Rgl (2-1 000μmol · L-1 ) and ginsenoside Rb1 (2-200 μmol · L-1 ) had no inhibitory effect on CYP3A4. Ginsenoside Rb1( 1 000 μmol · L-1 ) had mild inhibitory action on CYP3A4, and notoginsenoside R1(2-1 000μmol · L-1 ) showed the inhibition with IC50 of 126 μmol · L-1 ( 〉 100 μmol · L-1 ). Conclusion: The 3 kinds of Panax notoginsenosides have different inhibitory action on human liver microsomes CYP3A4 in vitro. Panax notoginsenosides ex- hibit limited inhibition on CYP3A4, so show little interaction with the drugs metabolized by CYP3A4.
Keywords:Notoginsenoside R1  Ginsenoside Rg1  Ginsenoside Rb1  CYP3A4  Inhibition
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《中国药师》浏览原始摘要信息
点击此处可从《中国药师》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号